Ahmed Magdy Rabea, Assistant Professor of Medical Oncology and Hematology at National cancer institute, shared a post on LinkedIn by AstraZeneca, adding:
“It was a pleasure visiting Libya and discussing the data with such an esteemed and brilliant physicians…
Thank you AstraZeneca for giving me such opportunity and for your continuous support regarding education and exchange of experience
Quoting AstraZeneca’s post:
“AstraZeneca Libya is proud to reinforce its commitment to advancing oncology care through a first-of-its-kind expert discussion on gastric and gastroesophageal cancers, in partnership with the National Cancer Care Authority (NCCA).
Bringing together leading oncology experts from across Libya, and chaired by Professor Ahmed Magdy Rabea, globally recognized expert in immunotherapy from Egypt, whose leadership brought a valuable regional and international perspective, the session created a strong platform for scientific exchange, discussing key challenges across epidemiology, diagnosis, and treatment – supporting progress toward more patient-centered care and improved outcomes across Libya.
Endorsed by Dr. Haidar Al-Saeh, President of the National Cancer Care Authority, the initiative reflects a shared commitment to advancing more coordinated, evidence-based approaches to cancer care in line with national priorities.”
More posts from Ahmed Magdy Rabea on OncoDaily.
